Sort
16,179 grants matching “malaria”
Malaria Parasite Sexual Development, Drug Resistance, and Evolution
$1,103,125Xinzhuan Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Defining the resistome in P. falciparum: evolution and mechanism
$1,102,586Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2024 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria
$1,101,631Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2009 · AI
Mali International Center for Excellence in Research: Malaria Clinical Research
$1,100,665Ruth Ellis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
VACCINE AND TREATMENT EVALUATION UNITS
$1,100,000Karen L. Kotloff · University Of Maryland Baltimore · N01 · FY2011 · AI
ICEMR Mali- Administrative Core
$1,099,253Seydou Doumbia · Univ Of Sciences, Tech & Tech Of Bamako · U19 · FY2021 · AI
Development of Antimalarial Preclinical Candidates
$1,099,224R Kiplin Guy · St. Jude Children'S Research Hospital · U01 · FY2010 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,098,906Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Structure and function of eukaryotic DNA transposases
$1,096,040Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
International Clinical Trials Unit
$1,095,343Duke University · U01 · FY2005 · AI
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
$1,094,503Seattle Biomedical Research Institute · U19 · FY2005 · AI
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa
$1,094,400Solomon Fiifi Ofori-Acquah · University Of Ghana · U54 · FY2020 · HL
Malaria Parasite Ligands And Host Cell Receptors
$1,092,399Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Impact of gene-drive systems for population modification on malaria vector mosquitoes
$1,092,110Anthony A James · University Of California-Irvine · R01 · FY2023 · AI
The Universidade Eduardo Mondlane/UCSD Medical Education Partnership
$1,092,000Emilia Virginia Noormahomed · Eduardo Mondlane University · R24 · FY2010 · TW
Malaria Vaccine Trials in Mali
$1,090,936Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2007 · AI
Development of Antimalarial Preclinical Candidates
$1,089,481R Kiplin Guy · St. Jude Children'S Research Hospital · U01 · FY2011 · AI
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
$1,089,350Moriya Tsuji · Columbia University Health Sciences · N01 · FY2024 · AI
DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study
$1,088,316Douglas Postels · Children'S Research Institute · U01 · FY2021 · AI
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa
$1,088,120Solomon Fiifi Ofori-Acquah · University Of Ghana · U54 · FY2021 · HL
Optimized Combination Antimalarial Drug Therapy
$1,087,190Paul D. Roepe · Georgetown University · R01 · FY2015 · AI
Development of Antimalarial Preclinical Candidates
$1,087,113R Kiplin Guy · St. Jude Children'S Research Hospital · U01 · FY2007 · AI
Defining the resistome in P. falciparum: evolution and mechanism
$1,083,911Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2023 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,083,730Thomas Meek · Texas A&M Agrilife Research · R01 · FY2017 · AI
Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.
$1,083,506B. Kim Lee Sim · Sanaria, Inc. · U01 · FY2024 · AI